• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-连环蛋白在间变性甲状腺癌中的频繁突变与核定位

Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.

作者信息

Garcia-Rostan G, Tallini G, Herrero A, D'Aquila T G, Carcangiu M L, Rimm D L

机构信息

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

出版信息

Cancer Res. 1999 Apr 15;59(8):1811-5.

PMID:10213482
Abstract

Beta-catenin is an ubiquitously expressed cytoplasmic protein that has a crucial role in both E-cadherin-mediated cell-cell adhesion and as a downstream signaling molecule in the wingless pathway. Stabilization of beta-catenin followed by nuclear translocation and subsequent T-cell factor/lymphoid-enhancing factor-mediated transcriptional activation has been proposed as an important step in oncogenesis. Stabilization may occur through activating mutations in exon-3 at the phosphorylation sites for ubiquitination and degradation of beta-catenin. Immunohistochemical subcellular localization of beta-catenin and mutational analysis of exon-3 of the beta-catenin gene by single-strand conformational polymorphism followed by DNA sequencing was performed on 37 samples from 31 patients with anaplastic thyroid carcinoma. Immunofluorescent staining showed nuclear localization in 15 (42%) of the 36 samples examined. Nucleotide sequencing of mobility shifts detected by single-strand conformational polymorphism revealed somatic alterations in 19 (61%) of the 31 patients analyzed. We conclude that mutations in beta-catenin are common in anaplastic thyroid cancer and that they may activate transcription, as illustrated by frequent nuclear localization of the protein. These findings support the idea that beta-catenin acts as an oncogene and contributes to the highly aggressive behavior of this tumor.

摘要

β-连环蛋白是一种广泛表达的细胞质蛋白,在E-钙黏蛋白介导的细胞间黏附中起关键作用,同时也是无翅通路中的下游信号分子。β-连环蛋白的稳定化,随后的核转位以及随后的T细胞因子/淋巴增强因子介导的转录激活被认为是肿瘤发生中的重要步骤。稳定化可能通过β-连环蛋白泛素化和降解的磷酸化位点外显子3中的激活突变而发生。对31例间变性甲状腺癌患者的37个样本进行了β-连环蛋白的免疫组织化学亚细胞定位以及通过单链构象多态性随后进行DNA测序对β-连环蛋白基因外显子3进行突变分析。免疫荧光染色显示,在检查的36个样本中有15个(42%)出现核定位。通过单链构象多态性检测到的迁移率变化的核苷酸测序显示,在分析的31例患者中有19例(61%)存在体细胞改变。我们得出结论,β-连环蛋白突变在间变性甲状腺癌中很常见,并且它们可能激活转录,正如该蛋白频繁的核定位所示。这些发现支持了β-连环蛋白作为癌基因起作用并促成该肿瘤高度侵袭性行为的观点。

相似文献

1
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.β-连环蛋白在间变性甲状腺癌中的频繁突变与核定位
Cancer Res. 1999 Apr 15;59(8):1811-5.
2
Beta-catenin mutations in biliary tract cancers: a population-based study in China.胆管癌中β-连环蛋白突变:一项基于中国人群的研究。
Cancer Res. 2001 Apr 15;61(8):3406-9.
3
[Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries].[卵巢上皮癌中β-连环蛋白基因的突变分析]
Orv Hetil. 2000 May 21;141(21):1115-9.
4
Beta-catenin mutations in human prostate cancer.人类前列腺癌中的β-连环蛋白突变
Cancer Res. 1998 Jun 15;58(12):2520-3.
5
Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.β-连环蛋白膜表达缺失与皮肤黑色素瘤的肿瘤进展相关,且很少由外显子3突变引起。
Mod Pathol. 2002 Apr;15(4):454-61. doi: 10.1038/modpathol.3880546.
6
Beta-catenin mutation in carcinoma of the uterine endometrium.子宫内膜癌中的β-连环蛋白突变
Cancer Res. 1998 Aug 15;58(16):3526-8.
7
Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix.β-连环蛋白基因第3外显子无突变的细胞质/细胞核表达在子宫颈肿瘤发生过程中很常见。
Gynecol Oncol. 2001 Sep;82(3):450-5. doi: 10.1006/gyno.2001.6298.
8
Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.N-丁基-N-(-4-羟丁基)亚硝胺诱导的小鼠膀胱癌中β-连环蛋白和γ-连环蛋白的改变
Cancer Res. 2001 Oct 1;61(19):7101-9.
9
Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.上皮性和间叶性肝母细胞瘤中β-连环蛋白的激活
Oncogene. 2000 Jan 27;19(4):498-504. doi: 10.1038/sj.onc.1203356.
10
Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.β-连环蛋白和E-钙黏蛋白在胃腺瘤-癌序列中的表达
Anticancer Res. 2003 May-Jun;23(3C):2863-8.

引用本文的文献

1
KSRP-mediated Wnt/β-catenin activation promotes follicular thyroid cancer progression and stemness.KSRP介导的Wnt/β-连环蛋白激活促进滤泡性甲状腺癌进展和干性。
Br J Cancer. 2025 Aug 23. doi: 10.1038/s41416-025-03142-x.
2
Wnt/β-catenin signaling is a therapeutic target in anaplastic thyroid carcinoma.Wnt/β-catenin 信号通路是间变性甲状腺癌的治疗靶点。
Endocrine. 2024 Oct;86(1):114-118. doi: 10.1007/s12020-024-03887-0. Epub 2024 May 28.
3
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.
甲状腺癌中的基因改变介导对BRAF抑制的抗性和间变性转化。
Oncotarget. 2024 Jan 24;15:36-48. doi: 10.18632/oncotarget.28544.
4
Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer.二甲双胍:癌症中 Wnt 信号通路的一种新抑制剂。
Cells. 2023 Aug 30;12(17):2182. doi: 10.3390/cells12172182.
5
Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer.谷氨酰胺分解和一碳代谢的共抑制促进 ROS 积累,从而增强间变性甲状腺癌的化疗疗效。
Cell Death Dis. 2023 Aug 12;14(8):515. doi: 10.1038/s41419-023-06041-2.
6
Does the likelihood of malignancy in thyroid nodules with RAS mutations increase in direct proportion with the allele frequency percentage?甲状腺结节 RAS 突变的恶性可能性是否与等位基因频率百分比成正比增加?
J Otolaryngol Head Neck Surg. 2023 Feb 11;52(1):12. doi: 10.1186/s40463-022-00611-8.
7
Vitamin D receptor regulates proliferation and differentiation of thyroid carcinoma via the E-cadherin-β-catenin complex.维生素 D 受体通过 E-钙黏蛋白-β-连环蛋白复合物调节甲状腺癌的增殖和分化。
J Mol Endocrinol. 2022 Mar 1;68(3):137-151. doi: 10.1530/JME-21-0167.
8
Bibliometric Insights in Advances of Anaplastic Thyroid Cancer: Research Landscapes, Turning Points, and Global Trends.间变性甲状腺癌进展的文献计量学见解:研究概况、转折点及全球趋势
Front Oncol. 2021 Nov 24;11:769807. doi: 10.3389/fonc.2021.769807. eCollection 2021.
9
Recurrent CTNNB1 mutations in craniofacial osteomas.颅面部骨瘤中 CTNNB1 的反复突变。
Mod Pathol. 2022 Apr;35(4):489-494. doi: 10.1038/s41379-021-00956-x. Epub 2021 Nov 1.
10
Epigenetic Silencing of SOX15 Is Controlled by miRNAs rather than Methylation in Papillary Thyroid Cancer.甲状腺乳头癌中 SOX15 的表观遗传沉默受 miRNA 而非甲基化调控。
Dis Markers. 2021 Sep 24;2021:1588220. doi: 10.1155/2021/1588220. eCollection 2021.